Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-18-012113

Chief Medical Officer sold 16,160 shares at $30.00 ($484,800)

  • Chief Medical Officer acquired 16,160 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HUMPHREY RACHEL · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-02 Exercise or conversion : show line 1 in the form +16,160 $6.61 $106,894 46,394 D
2018-03-02 Sale : show line 2 in the form −16,160 $30.00 $484,800 30,234 D
Open-market sales · 16,160 sh · avg $30.00 · $484,800

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-03-02 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −16,160 222,980 D
Loading xslF345X03/doc1.xml…